REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough blood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a new type of cell therapy for people with certain blood cancers (like lymphoma and leukemia) that have returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better recogni…
Matched conditions: REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated May 26, 2026 10:37 UTC
-
New CAR t-cell therapy aims to beat childhood leukemia
Disease control Recruiting nowThis early-stage trial tests a new type of immune cell therapy (CMD63) in 16 children whose B-cell acute lymphoblastic leukemia has returned or not responded to standard treatments. The therapy uses the patient's own modified T cells to target and kill cancer cells. The main goal…
Matched conditions: REFACTORY CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated May 26, 2026 10:31 UTC